Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Morkel

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Cell Death & Disease|July 3, 2020
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastropheBastian Gastl, Kathleen Klotz-Noack, Bertram Klinger, et al.
Oncotarget|July 23, 2016
Oncogenic Ras triggers hyperproliferation and impairs polarized colonic morphogenesis by autocrine ErbB3 signalingYvonne Möller, Markus Morkel, Jens Schmid, et al.
Stem Cell Research & Therapy|October 8, 2025
Elimination of CDX2 restricts intestinal hybrid differentiation signatures in stem cell-derived hepatocyte-like cellsPatrick Nell, Antonia Thomitzek, David Feuerborn, et al.
International Journal of Cancer|September 26, 2018
Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancerFelix Bormann, Sebastian Stinzing, Sascha Tierling, et al.
Plos Genetics|February 15, 2013
DNA-methylome analysis of mouse intestinal adenoma identifies a tumour-specific signature that is partly conserved in human colon cancerChristina Grimm, Lukas Chavez, Mireia Vilardell, et al.
International Journal of Cancer|March 9, 2022
The single-cell transcriptional landscape of lung carcinoid tumorsPhilip Bischoff, Alexandra Trinks, Jennifer Wiederspahn, et al.
Science Signaling|July 22, 2025
Reporter-based screening identifies RAS-RAF mutations as drivers of resistance to active-state RAS inhibitors in colorectal cancerOleksandra Aust, Moritz R T Thiel, Eric Blanc, et al.
Nature Communications|July 4, 2019
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epitheliumRaphael Brandt, Thomas Sell, Mareen Lüthen, et al.
Nature Communications|October 5, 2022
Helicobacter pylori shows tropism to gastric differentiated pit cells dependent on urea chemotaxisCarmen Aguilar, Mindaugas Pauzuolis, Malvika Pompaiah, et al.
Med (New York, N.Y.)|December 7, 2024
Diagnosing recipient- vs. donor-derived posttransplant myelodysplastic neoplasm via targeted single-cell mutational profilingJana Ihlow, Livius Penter, Lam Giang Vuong, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cell Death & Disease|July 3, 2020
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastropheBastian Gastl, Kathleen Klotz-Noack, Bertram Klinger, et al.
Oncotarget|July 23, 2016
Oncogenic Ras triggers hyperproliferation and impairs polarized colonic morphogenesis by autocrine ErbB3 signalingYvonne Möller, Markus Morkel, Jens Schmid, et al.
Stem Cell Research & Therapy|October 8, 2025
Elimination of CDX2 restricts intestinal hybrid differentiation signatures in stem cell-derived hepatocyte-like cellsPatrick Nell, Antonia Thomitzek, David Feuerborn, et al.
International Journal of Cancer|September 26, 2018
Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancerFelix Bormann, Sebastian Stinzing, Sascha Tierling, et al.
Plos Genetics|February 15, 2013
DNA-methylome analysis of mouse intestinal adenoma identifies a tumour-specific signature that is partly conserved in human colon cancerChristina Grimm, Lukas Chavez, Mireia Vilardell, et al.
International Journal of Cancer|March 9, 2022
The single-cell transcriptional landscape of lung carcinoid tumorsPhilip Bischoff, Alexandra Trinks, Jennifer Wiederspahn, et al.
Science Signaling|July 22, 2025
Reporter-based screening identifies RAS-RAF mutations as drivers of resistance to active-state RAS inhibitors in colorectal cancerOleksandra Aust, Moritz R T Thiel, Eric Blanc, et al.
Nature Communications|July 4, 2019
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epitheliumRaphael Brandt, Thomas Sell, Mareen Lüthen, et al.
Nature Communications|October 5, 2022
Helicobacter pylori shows tropism to gastric differentiated pit cells dependent on urea chemotaxisCarmen Aguilar, Mindaugas Pauzuolis, Malvika Pompaiah, et al.
Med (New York, N.Y.)|December 7, 2024
Diagnosing recipient- vs. donor-derived posttransplant myelodysplastic neoplasm via targeted single-cell mutational profilingJana Ihlow, Livius Penter, Lam Giang Vuong, et al.
Pageof 5